Allergan makes the oxymetazoline based Rhofade, a topical that used to treat the red face of rosacea. Allergan is also known to rosacea sufferers because they make Restasis and Aczone.

Recent Rosacea Blog Posts

Vicept Oxymetazoline V-101 Cream More Phase II Data, on to Phase III

A Press Release today (Vicept are happy to generate publicity at every step of their development) touting more Phase II Study results for their Oxymetazoline based V-101 product. V-101 is a topical slated to treat the redness of rosacea. The first Phase II trial results for V-101 were announced just 3 months ago. It isn’t […]

Continue Reading

Oxymetazoline: what about rebound redness ?

One of the up and coming treatments for the redness of rosacea is the use of oxymetazoline based formulations. Oxymetazoline is the active ingredient in decongestant products like Afrin, Sudafed OM and Vicks Sinex as well as in eye drops like Visine LR. Recent publicity from Vicept Therapetics suggests that their product in development V-101 […]

Continue Reading

FDA gets tough with Allergan over Aczone

The FDA has issued a warning letter to Allergan, the makers of Aczone for overstating the efficacy of Aczone and also for understating the possible side effects. In a sign that the FDA is watching carefully the claims that vendors use when advertising their products, the warning letter calls out a journal advertisement for Aczone […]

Continue Reading

Allergan buys Aczone, has plans for rosacea targeting ?

OK this story is getting so much coverage in the online press that I thought I should cover it here too. Allergan is buying the topical dapsone product called Aczone for $150m. From: Allergan Announces Agreement to Acquire Aczone(R) Gel 5% “Aczone(R) Gel 5% is the first new chemical entity approved by the FDA for […]

Continue Reading



Subscribe to Rosacea News

Enter your email address to receive the latest news about rosacea in your inbox.